Unknown

Dataset Information

0

Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy.


ABSTRACT: Nanomedicines have shown great potential in cancer therapy; in particular, the combination of chemotherapy and immunotherapy (namely chemoimmunotherapy) that is revolutionizing cancer treatment. Currently, most nanomedicines for chemoimmunotherapy are still in preclinical and clinical trials. Lipid-based nanoparticles, the most widely used nanomedicine platform in cancer therapy, is a promising delivery platform for chemoimmunotherapy. In this review, we introduce the commonly used immunotherapy agents and discuss the opportunities for chemoimmunotherapy mediated by lipid-based nanoparticles. We summarize the clinical trials involving lipid-based nanoparticles for chemoimmunotherapy. We also highlight different chemoimmunotherapy strategies based on lipid-based nanoparticles such as liposomes, nanodiscs, and lipid-based hybrid nanoparticles in preclinical research. Finally, we discuss the challenges that have hindered the clinical translation of lipid-based nanoparticles for chemoimmunotherapy, and their future perspectives.

SUBMITTER: Wang T 

PROVIDER: S-EPMC8069739 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7645050 | biostudies-literature
| S-EPMC7406478 | biostudies-literature
| S-EPMC7247422 | biostudies-literature
| S-EPMC9787894 | biostudies-literature
| S-EPMC10058222 | biostudies-literature
| S-EPMC6920925 | biostudies-literature
| S-EPMC10407046 | biostudies-literature
| S-EPMC10797422 | biostudies-literature
| S-EPMC8069998 | biostudies-literature
| S-EPMC8731178 | biostudies-literature